RIVAROXABAN Form I contains not less than 98.0% and not more than 102.0% of C19H18ClN3O5S, calculated on the anhydrous basis.

利伐抑凝因
RIVAROXABAN

申請商
西海生技股份有限公司 
適應症
抗凝血劑
含量
0